Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement

Launched by BAYLOR COLLEGE OF MEDICINE · Aug 27, 2024

Keywords

ClinConnect Summary

Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women and persons with a cervix. Using mailed self-sampling kits to test for high-risk human papillomavirus (HPV), the virus that causes cervical cancer, may overcome multiple barriers to clinic-based screening. The parent study (NCT03898167) is a randomized controlled trial to compare the effectiveness of three outreach interventions to increase primary screening participation and clinical follow-up among underscreened women a in a safety net health system. The three strat...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Asian ethnicity reported in the electronic health record
• • no history of hysterectomy or cervical cancer
• • no Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years
• • patient of Harris Health System in Harris County (Houston), Texas
• • have at least 2 visits to ambulatory care within Harris Health System in the past 5 years
• • be currently enrolled in a healthcare coverage or financial assistance plan accepted by Harris Health System or have been enrolled in a Harris Health coverage plan in the past 12 months
• Exclusion Criteria:
• • no valid telephone contact information
• • unable to communicate in English, Vietnamese or Spanish
• • currently pregnant
• • history of cervical dysplasia in the past 3.5 years